Advisor Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $621K | Buy |
1,254
+114
| +10% | +$56.5K | 0.04% | 415 |
|
|
2022
Q1 | $642K | Sell |
1,140
-10
| -0.9% | -$5.63K | 0.04% | 437 |
|
|
2021
Q4 | $869K | Buy |
1,150
+135
| +13% | +$102K | 0.05% | 345 |
|
|
2021
Q3 | $757K | Sell |
1,015
-48
| -5% | -$35.8K | 0.05% | 363 |
|
|
2021
Q2 | $685K | Sell |
1,063
-67
| -6% | -$43.2K | 0.05% | 403 |
|
|
2021
Q1 | $645K | Buy |
1,130
+53
| +5% | +$30.3K | 0.05% | 401 |
|
|
2020
Q4 | $628K | Buy |
1,077
+68
| +7% | +$39.7K | 0.05% | 380 |
|
|
2020
Q3 | $520K | Buy |
1,009
+50
| +5% | +$25.8K | 0.04% | 381 |
|
|
2020
Q2 | $433K | Buy |
959
+27
| +3% | +$12.2K | 0.04% | 402 |
|
|
2020
Q1 | $326K | Buy |
932
+94
| +11% | +$32.9K | 0.04% | 414 |
|
|
2019
Q4 | $315K | Buy |
838
+1
| +0.1% | +$376 | 0.03% | 484 |
|
|
2019
Q3 | $279K | Buy |
837
+7
| +0.8% | +$2.33K | 0.03% | 495 |
|
|
2019
Q2 | $259K | Sell |
830
-15
| -2% | -$4.68K | 0.03% | 506 |
|
|
2019
Q1 | $258K | Sell |
845
-27
| -3% | -$8.24K | 0.03% | 493 |
|
|
2018
Q4 | $202K | Buy |
872
+7
| +0.8% | +$1.62K | 0.03% | 549 |
|
|
2018
Q3 | $271K | Sell |
865
-4
| -0.5% | -$1.25K | 0.04% | 490 |
|
|
2018
Q2 | $251K | Buy |
869
+14
| +2% | +$4.04K | 0.04% | 473 |
|
|
2018
Q1 | $214K | Sell |
855
-71
| -8% | -$17.8K | 0.04% | 509 |
|
|
2017
Q4 | $236K | Buy |
926
+2
| +0.2% | +$510 | 0.04% | 480 |
|
|
2017
Q3 | $205K | Sell |
924
-1
| -0.1% | -$222 | 0.04% | 458 |
|
|
2017
Q2 | $209K | Buy |
+925
| New | +$209K | 0.05% | 431 |
|